Movano Health Announces Blood Pressure Partnership Forum Following Significant Response to Groundbreaking Accuracy Achievement
PLEASANTON, Calif., Dec. 12, 2023 /PRNewswire/ — Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced that following the successful results of its recent blood pressure clinical trial it will be holding in person demonstrations of live waveforms at both the 2024 CES Show in Las Vegas January 8-11, 2024 and in conjunction with the JP Morgan Healthcare Conference in San Francisco January 9-10, 2024.
Related news for (MOVE)
- MoBot alert highlights: NASDAQ: MOVE, NASDAQ: AIHS, NASDAQ: NXTT, NASDAQ: STTK, NASDAQ: IPDN (09/03/25 10:00 AM)
- Morning Market Recap: Precision Medicine Clears the Path, A&D Soars, and Gaming Gets a Buyback Boost
- Breaking News: MoBot’s Latest Update as of 08/29/25 09:00 AM
- Today’s Top Performers: MoBot’s Market Review 08/29/25 08:00 AM
- Breaking News: MoBot’s Latest Update as of 08/29/25 06:00 AM